Naturally occurring phenolic acids modulate TPA-induced activation of EGFR, AP-1, and STATs in mouse epidermis

Michał Cichocki1, Miłosz Dałek, Mateusz Szamałek

  • 1a Department of Pharmaceutical Biochemistry , Poznan University of Medical Sciences , Poznań , Poland.

Nutrition and Cancer
|January 2, 2014
PubMed

Insights

Naturally occurring phenolic acids inhibit tumor development by blocking key signaling pathways. These compounds, like tannic and protocatechuic acid, reduce epidermal growth factor receptor (EGFR) and activator protein-1 (AP-1) activation, and inhibit signal transducers and activators of transcription (STATs).

Area of Science:

  • Oncology
  • Molecular Biology
  • Natural Products Chemistry

Background:

  • Epidermal growth factor receptor (EGFR) is crucial in epithelial carcinogenesis and STATs activation.
  • Tumor promoters like 12-O-tetradecanoylphorbol-13-acetate (TPA) activate EGFR, AP-1, and STATs pathways in the epidermis.
  • Naturally occurring phenolic acids are investigated for their potential to modulate these cancer-related signaling pathways.

Purpose of the Study:

  • To investigate the interference of phenolic acids with EGFR, AP-1, and STATs pathways activated by TPA in mouse epidermis.
  • To determine the specific effects of tannic acid, chlorogenic acid, and protocatechuic acid on these signaling cascades.
  • To elucidate the potential of phenolic acids in inhibiting tumor development by modulating these pathways.

Main Methods:

  • Topical application of TPA to Balb/c mice epidermis.
  • Pretreatment with naturally occurring phenolic acids (tannic, chlorogenic, protocatechuic acid).
  • Analysis of EGFR phosphorylation (Y-1068, Y-1173), AP-1 activation, c-Jun levels, JNK activity, and STATs activation.

Main Results:

  • Tannic and chlorogenic acids significantly decreased EGFR phosphorylation and AP-1 activation.
  • Tannic acid reduced c-Jun levels and binding to the TPA response element (TRE).
  • Protocatechuic acid inhibited STATs activation and increased JNK activity, while other phenolics primarily affected the EGFR/AP-1 pathway.

Conclusions:

  • Naturally occurring phenolic acids can inhibit tumor development by modulating EGFR, AP-1, and STATs activation.
  • Complex phenolics primarily target the EGFR/AP-1 pathway.
  • Simple phenolic compounds, like protocatechuic acid, are particularly effective inhibitors of STATs activation.

Related Concept Videos

Epistasis01:39

Epistasis

In addition to multiple alleles at the same locus influencing traits, numerous genes or alleles at different locations may interact and influence phenotypes in a phenomenon called epistasis. For example, rabbit fur can be black or brown depending on whether the animal is homozygous dominant or heterozygous at a TYRP1 locus. However, if the rabbit is also homozygous recessive at a locus on the tyrosinase gene (TYR), it will have an unshaded coat that appears white, regardless of its TYRP1...
37.3K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K